A higher proportion of cCTC+ve (40%) patients was observed for the BRAF V600E-negative group (40%) when compared to that for the BRAF V600E-positive group (14%), although this correlation did not reach statistical significance ( Table 2 ).
← all excerpts
Assessment of a Size-Based Method for Enriching Circulating Tumour Cells in Colorectal Cancer.
1
—
—